Health groups call on the leaders of the Western Balkan countries to harmonize national air quality standards with the World Health Organization Global air quality guidelines. Health experts should be actively involved in these decision-making processes to ensure the timely integration of public health measures into environmental policies. Compliance with WHO recommendations brings multiple benefits – reduced incidence of chronic diseases and premature deaths, reduced overall health costs and, most importantly, better health and higher productivity of people.
The governments of the European Union are in the process of deciding whether to relicense chlorpyrifos – a pesticide widely used across Europe that has serious negative effects on the health of our children. What can we learn from the last time this pesticide was approved on the European markets?
The Health and Environment Alliance (HEAL) is organising a new series of webinars dedicated to the health and environmental impacts of chlorpyrifos, a pesticide widely used across Europe.
In the third and final webinar of the series, we invited Dr. Axel Mie (Karolinska Institutet, Stockholm) and Dr. Christina Rudén (Stockholm University) to present their review of the two main industry-funded studies on developmental neurotoxicity of chlorpyrifos and chlorpyrifos-methyl. These industry-funded studies have played a central role in the previous market approval of chlorpyrifos in Europe.
Their review rebuts the conclusions of the industry studies on the absence of neurodevelopmental effects of both substances, identifying many failures, shortcomings and inadequate interpretation of raw data. It also uses this case study to discuss some aspects of the current pesticide approval procedures and possible health-protective ways forward.
Webinar #3: Lessons learned from the approval of chlorpyrifos
Wednesday 12 June, 17:00 – 18:00 CET